|
Dec 08
2009
|

A new just approved cancer drug, called Folotyn, will cost over $30,000 a month, which is at least triple that of other drugs that critics have said are too expensive for the benefits they offer to patients.
|
Dec 08
2009
|

A new just approved cancer drug, called Folotyn, will cost over $30,000 a month, which is at least triple that of other drugs that critics have said are too expensive for the benefits they offer to patients.